Test Bank For Abrams’ Clinical Drug Therapy Rationales for Nursing Practice 12th Edition Geralyn Frandsen

Test Bank For Abrams’ Clinical Drug Therapy Rationales for Nursing Practice 12th Edition Geralyn Frandsen - ISBN/ISSN 9781975136130 Table of Content SECTION 1 The Conceptual Framework of Pharmacology Chapter 1 The Foundation of Pharmacology: Quality and Safety Chapter 2 Basic Concepts and Processes Chapter 3 Medication Administration and the Nursing Process of Drug Therapy SECTION 2 Drug Therapy Throughout the Lifespan Chapter 4 Pharmacology and the Care of Infants and Pediatric Patients Medication Administration in Pediatrics Chapter 5 Pharmacology and the Care of Adults and Geriatric Patients Chapter 6 Pharmacology and the Care of Pregnant or Lactating Woman Chapter 7 Pharmacology and Women’s Health Chapter 8 Pharmacology and Men’s Health SECTION 3 Drugs Affecting the Hematopoietic and Immune Systems Chapter 9 Drug Therapy for Coagulation Disorders Chapter 10 Drug Therapy for Dyslipidemia Chapter 11 Drug Therapy for Hematopoietic Disorders Chapter 12 Drug Therapy: Immunizations Chapter 13 Drug Therapy to Decrease Immunity Chapter 14 Drug Therapy for the Treatment of Cancer SECTION 4 Drugs Affecting Inflammation and Infection Chapter 15 Inflammation, Infection, and the Use of Antimicrobial Agents Chapter 16 Drug Therapy to Decrease Pain, Fever, and Inflammation Chapter 17 Drug Therapy With Corticosteroids Chapter 18 Drug Therapy With Beta-Lactam Antibacterial Agents Chapter 19 Drug Therapy With Aminoglycosides and Fluoroquinolones Chapter 20 Drug Therapy With Tetracyclines, Sulfonamides, and Urinary Antiseptics Chapter 21 Drug Therapy With Macrolides and Miscellaneous Anti-infective Agents Chapter 22 Drug Therapy for Tuberculosis and Mycobacterium avium Complex Disease Chapter 23 Drug Therapy for Viral Infections Chapter 24 Drug Therapy for Fungal Infections Chapter 25 Drug Therapy for Parasitic Infections SECTION 5 Drugs Affecting the Cardiovascular System Chapter 26 Drug Therapy for Hypertension Chapter 27 Drug Therapy for Dysrhythmias Chapter 28 Drug Therapy for Coronary Heart Disease Chapter 29 Drug Therapy for Shock and Hypotension Chapter 30 Drug Therapy for Heart Failure SECTION 6 Drugs Affecting the Respiratory System Chapter 31 Drug Therapy for Nasal Congestion and Cough Chapter 32 Drug Therapy to Decrease Histamine Effects and Allergic Response Chapter 33 Drug Therapy for Asthma and Bronchoconstriction SECTION 7 Drugs Affecting the Renal and Digestive Systems Chapter 34 Drug Therapy for Fluid Volume Excess Chapter 35 Nutritional Support Products, Vitamins, and Mineral Supplements Chapter 36 Drug Therapy for Weight Management Chapter 37 Drug Therapy for Peptic Ulcer Disease and Hyperacidity Chapter 38 Drug Therapy for Nausea and Vomiting Chapter 39 Drug Therapy for Constipation and Elimination Problems Chapter 40 Drug Therapy for Diarrhea SECTION 8 Drugs Affecting the Endocrine System Chapter 41 Drug Therapy for Diabetes Mellitus Chapter 42 Drug Therapy for Hyperthyroidism and Hypothyroidism Chapter 43 Drug Therapy for Pituitary and Hypothalamic Dysfunction Chapter 44 Drug Therapy to Regulate Calcium and Bone Metabolism Chapter 45 Drug Therapy for Addison’s Disease and Cushing’s Disease Section 9 Drugs Affecting the Autonomic and Central Nervous System Chapter 46 Physiology of the Autonomic and Central Nervous Systems and Indications for the Use of Drug Therapy Chapter 47 Drug Therapy for Myasthenia Gravis, Alzheimer’s Disease, and Urinary Retention Chapter 48 Drug Therapy for Parkinson’s Disease, Urinary Spasticity, and Disorders Requiring Anticholinergic Drug Therapy Chapter 49 Drug Therapy With Opioids Chapter 50 Drug Therapy With Local Anesthetics Chapter 51 Drug Therapy With General Anesthetics Chapter 52 Drug Therapy for Migraines and Other Headaches Chapter 53 Drug Therapy for Seizure Disorders and Spasticity Chapter 54 Drug Therapy for Anxiety and Insomnia Chapter 55 Drug Therapy for Depression and Mood Stabilization Chapter 56 Drug Therapy for Psychotic Disorders Chapter 57 Drug Therapy for Attention Deficit Hyperactivity Disorder and Narcolepsy Chapter 58 Drug Therapy for Substance Abuse Disorders Section 10 Drugs Affecting the Eye, Ear, and Skin Chapter 59 Drug Therapy for Disorders of the Eye Chapter 60 Drug Therapy for Disorders of the Ear Chapter 61 Drug Therapy for Disorders of the Skin GRADESBOOST.COM Chapter 1, The Foundation of Pharmacology: Quality and Safety 1. A woman diagnosed with obsessive–compulsive disorder has been prescribed oral paroxetine hydrochloride. What is the expected effect for this prescription? A. Curative effect on symptoms B. Systemic effect on symptoms C. Local effect on symptoms D. Parenteral effect on symptoms ANS: B Rationale: Drugs that produce systemic effects are taken into the body, circulated through the bloodstream to their sites of action in various body tissues, and eventually eliminated from the body. Curative agents are given to cure a disease process. In this case, paroxetine hydrochloride will control the symptoms but not cure the disorder. Drugs with local effects, such as sunscreen and local anesthetics, act mainly at the site of application. Paroxetine hydrochloride is not administered parenterally. Parenteral agents are administered subcutaneously, intramuscularly, or intravenously. PTS: 1 REF: p. 3, Introduction OBJ: 1 NAT: Client Needs: Physiological Integrity: Pharmacological and Parenteral Therapies TOP: Chapter: 1: The Foundation of Pharmacology: Quality and Safety KEY: Integrated Process: Nursing Process BLM: Cognitive Level: Understand NOT: Multiple Choice 2. A client has been prescribed an antibiotic. This medication is a naturally occurring substance that has been cheGmRicAalDlyEmSoBdOifOieSd.TW.hCaOtMi s another name for this type of medication? A. Synthetic drug B. Semisynthetic drug C. Biotechnology drug D. Prototype drug ANS: B Rationale: Semisynthetic drugs (e.g., many antibiotics) are naturally occurring substances that have been chemically modified. Synthetic drugs are more standardized in their chemical characteristics, more consistent in their effects, and less likely to produce allergic reactions. Biotechnology drugs involve manipulating DNA and RNA and recombining genes into hybrid molecules that can be inserted into living organisms. Prototype drugs are the first drug of a particular group to be developed. PTS: 1 REF: p. 3, Drug Sources OBJ: 1 NAT: Client Needs: Physiological Integrity: Pharmacological and Parenteral Therapies TOP: Chapter: 1: The Foundation of Pharmacology: Quality and Safety KEY: Integrated Process: Nursing Process BLM: Cognitive Level: Understand NOT: Multiple Choice 3. Which classification applies to morphine? A. Central nervous system depressant B. Central nervous system stimulant GRADESBOOST.COM C. Anti-inflammatory D. Antihypertensive ANS: A Rationale: Drugs are classified according to their effects on particular body systems, their therapeutic uses, and their chemical characteristics. Morphine is classified as a central nervous system depressant and will produce this effect in the client. A central nervous system stimulant increases attention and raises mood. An anti-inflammatory agent decreases inflammation at the site of tissue or joint inflammation. An antihypertensive agent reduces blood pressure. PTS: 1 REF: p. 3, Drug Classifications and Prototypes OBJ: 1 NAT: Client Needs: Physiological Integrity: Pharmacological and Parenteral Therapies TOP: Chapter: 1: The Foundation of Pharmacology: Quality and Safety KEY: Integrated Process: Nursing Process BLM: Cognitive Level: Remember NOT: Multiple Choice 4. A client is administered amoxicillin. The generic name of this medication belongs to which drug group? A. Selective serotonin reuptake inhibitors B. Diuretics C. Penicillins D. ACE inhibitors ANS: C Rationale: The generic namG eR oA fteD nE iS ndB icO aO teS sT th. eC d rO u g group (e.g., drugs with generic names ending in “cillin” are penicillins). Selective serotonin reuptake inhibitors are medications that have antidepressant effects; SSRI is a broad classification, not a generic name. Diuretics are medications that increase urine output; diuretic is a broad classification, not a generic name. ACE inhibitor is the broad classification for the angiotensin receptor blockers, not the generic name. PTS: 1 REF: p. 3, Drug Names OBJ: 2 NAT: Client Needs: Physiological Integrity: Pharmacological and Parenteral Therapies TOP: Chapter: 1: The Foundation of Pharmacology: Quality and Safety KEY: Integrated Process: Nursing Process BLM: Cognitive Level: Understand NOT: Multiple Choice 5. The administration of diphenhydramine is regulated by which U.S. government agency? A. Public Health Service B. Federal Trade Commission C. Occupational Safety and Health Administration D. Food and Drug Administration GRADESBOOST.COM ANS: C Rationale: The Food and Drug Administration approves drugs for over-the-counter availability, including the transfer of drugs from prescription to OTC status, and may require clinical trials to determine the safety and effectiveness of OTC use. The Public Health Service is regulated by the state to maintain the health of individual citizens of the state. The Federal Trade Commission regulates imports and exports throughout the nation. The Occupational Safety and Health Administration regulates safety within the workplace.